Levels of pro-inflammatory cytokines, such as IL-1β, IL-6, and IL-8, are elevated in serum or plasma samples obtained from patients with AML compared to age-matched healthy controls [8,9]. This evidence concerns the gene IL1B and acute myeloid leukemia.